3.8 Review

Evaluation of the role of povidone-iodine in the prevention of surgical site infections

Journal

SURGERY OPEN SCIENCE
Volume 13, Issue -, Pages 9-17

Publisher

ELSEVIER
DOI: 10.1016/j.sopen.2023.03.005

Keywords

Surgical site infection; Antiseptic; Povidone-iodine; Wound healing; Decolonization

Categories

Ask authors/readers for more resources

The use of PVP-I at all stages of surgical intervention, from preoperative measures to postoperative wound management, is supported by scientific evidence. However, more stringent study designs are needed in clinical trials to compare antiseptic agents effectively, especially for preoperative skin preparation.
Background: The occurrence of surgical site infections (SSIs) is associated with increased risk of mortality, devel-opment of other infections, and the need for reintervention, posing a significant health burden. The aim of this review was to examine the current data and guidelines around the use of antiseptic povidone-iodine (PVP-I) for the prevention of SSIs at each stage of surgical intervention. Methods: A literature search for selected key words was performed using PubMed. Additional papers were iden-tified based on author expertise. Results: Scientific evidence demonstrates that PVP-I can be used at every stage of surgical intervention: preoper-ative, intraoperative, and postoperative. PVP-I is one of the most widely used antiseptics on healthy skin and mu-cous membranes for preoperative surgical site preparation and is associated with a low SSI rate. For intraoperative irrigation, aqueous PVP-I is the recommended agent and has been demonstrated to decrease SSIs in a range of surgical settings, and for postoperative wound healing, there is a growing body of evidence to support the use of PVP-I. Conclusions: There is a need for more stringent study designs in clinical trials to enable meaningful comparisons between antiseptic agents, particularly for preoperative skin preparation. The use of a single agent (PVP-I) at each stage of surgical intervention could potentially provide advantages, including economic benefits, over agents that can only be used at discrete stages of the surgical procedure. Key message: Evidence supports the use of PVP-I at all stages of surgical intervention, from preoperative measures (including skin preparation, preoperative washing, and nasal decolonization) to intraoperative irrigation, through to postoperative wound management. However, there is a need for more stringent study designs in clinical trials to enable meaningful comparisons between antiseptic agents, particularly for preoperative skin preparation. (c) 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available